Interventional Pericardiology 2011
DOI: 10.1007/978-3-642-11335-2_10
|View full text |Cite
|
Sign up to set email alerts
|

Intrapericardial Treatment in Pericardial Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 102 publications
0
1
0
Order By: Relevance
“…The direct intrapericardial application of drugs has the advantage of giving a high local dose with little systemic side effects. 6 Another study by the same group evaluated the efficacy and safety of intrapericardial treatment with the crystalloid corticosteroid triamcinolone in autoreactive pericardial effusion; it found that it resulted in symptomatic improvement and prevented recurrence in 92.6% of patients after 3 months and in 86.0% after 1 year. 7 The symptoms were preceded by mild upper respiratory tract infection, but there was no history of fever.…”
Section: Data Reviewmentioning
confidence: 99%
“…The direct intrapericardial application of drugs has the advantage of giving a high local dose with little systemic side effects. 6 Another study by the same group evaluated the efficacy and safety of intrapericardial treatment with the crystalloid corticosteroid triamcinolone in autoreactive pericardial effusion; it found that it resulted in symptomatic improvement and prevented recurrence in 92.6% of patients after 3 months and in 86.0% after 1 year. 7 The symptoms were preceded by mild upper respiratory tract infection, but there was no history of fever.…”
Section: Data Reviewmentioning
confidence: 99%